Cravath Swaine & Moore

United States

Worldwide Plaza, 825 Eighth Avenue
New York
NY 10019
United States

+1 212 474 1000

+1 212 474 3700

Cravath, Swaine & Moore LLP has been known as one of the world’s preeminent law firms for over two centuries. Each of its practices is highly regarded and its lawyers are recognized for their commitment to the representation of their clients’ interests in the United States and internationally.
Cravath represents a full spectrum of companies, from biotechnology startups to established healthcare and life sciences companies, on a variety of corporate and litigation matters. We have played a leading role in critical and complex transactions and cases that have defined the life sciences industry, including handling one of the first suits to proceed under the Biologics Price Competition and Innovation Act, in which we represented Amgen in a lawsuit arising from its anticipated introduction of the first biosimilar to AbbVie’s biologic drug, Humira®.

The Firm represents pharmaceutical, biotechnology, healthcare services and medical device companies in significant intellectual property and antitrust litigation; complex shareholder derivative and securities suits; breach of contract and licensing disputes; and arbitrations. We also handle government and internal investigations; regulatory enforcement; and compliance matters for life sciences clients, as well as regulatory clearance and antitrust advice relating to mergers and acquisitions.

On the corporate side, we advise life sciences companies and their boards of directors in connection with transactions ranging from complex collaboration agreements to a wide variety of acquisitions and divestitures of companies and businesses. Clients also rely on our financing expertise as well as our experience in navigating risks and strategies related to environmental, social and governance (“ESG”) issues.

Intellectual property issues are critical for many of our clients in the life sciences sector. We have significant expertise across a broad range of intellectual property issues including strategic counseling, review and analysis in developing and optimizing intellectual property rights, patents, licensing and portfolio development and exploitation.

Cravath’s clients in this area have included: Abiomed, Actelion, Akorn, Alcon, Amgen, Chemed, CRISPR Therapeutics, Illumina, Insys Therapeutics, IsoPlexis, Medinol, Merck & Co., Novartis, OrbusNeich, RedHill Biopharma, Roivant Sciences, Thermo Fisher Scientific, Vaxxinity, Viatris and Vitaworks.

2021 LMG Life Sciences Stars:
• Evan R. Chesler
• Keith R. Hummel
• David J. Kappos